As we wrap up the year we are excited to share some exciting end of the year successes: -We were able to work with one of clients to impact FDA guidance on rare disease clinical trial design: https://lnkd.in/edn2sN5R -We got alignment on our DMA primary endpoint
Psychlomere, LLC
Business Consulting and Services
Littleton, CO 225 followers
Development and Endpoint Solutions For Clinical Trials
About us
At Psychlomere, our mission is to empower effective treatments to reach patients in need by enhancing clinical trial design and ensuring robust, meaningful endpoints for CNS and rare disease clinical trials. Our team of clinical psychologists, uniquely trained in clinical study design, psychometric development, and endpoint evaluation, leverages our innovative Psychlomere Framework to accelerate the creation of trial-ready, regulatory-successful endpoints. From concept to completion, we deliver patient-centered clinical outcome assessments (COAs) and biomarkers for scalable, decentralized trials. Partner with us to unlock the full potential of your clinical research and deliver transformative treatments to the world.
- Website
-
psychlomere.com
External link for Psychlomere, LLC
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Headquarters
- Littleton, CO
- Type
- Self-Owned
- Specialties
- Clinical Development, Clinical Operations, Externally Sponsored Studies, Regulatory & Advisory Board, Clinical Trials, Endpoint Solutions, Rare Disease, CNS Disorders, Biomarkers, EEG, fMRI, Eye-tracking, and Clinical Psychology
Locations
-
Primary
Get directions
Littleton, CO 80123, US